These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 29107207)
1. Association of serum gamma-glutamyltransferase and C-reactive proteins with neuromyelitis optica and multiple sclerosis. Shu Y; Li R; Qiu W; Chang Y; Sun X; Fang L; Chen C; Yang Y; Lu Z; Hu X; Kermode AG Mult Scler Relat Disord; 2017 Nov; 18():65-70. PubMed ID: 29107207 [TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier disruption is more severe in neuromyelitis optica than in multiple sclerosis and correlates with clinical disability. Tomizawa Y; Yokoyama K; Saiki S; Takahashi T; Matsuoka J; Hattori N J Int Med Res; 2012; 40(4):1483-91. PubMed ID: 22971500 [TBL] [Abstract][Full Text] [Related]
3. Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica. Yang T; Wang S; Zheng Q; Wang L; Li Q; Wei M; Du Z; Fan Y BMC Neurol; 2016 Jul; 16():96. PubMed ID: 27401736 [TBL] [Abstract][Full Text] [Related]
4. Low vitamin D-25(OH) level in Indonesian multiple sclerosis and neuromyelitis optic patients. Kusumadewi W; Imran D; Witjaksono F; Pakasi TA; Rusmana AI; Pangeran D; Marwadhani SS; Maharani K; Estiasari R Mult Scler Relat Disord; 2018 Oct; 25():329-333. PubMed ID: 30195201 [TBL] [Abstract][Full Text] [Related]
5. Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica. Wang H; Wang K; Wang C; Zhong X; Qiu W; Hu X Mult Scler; 2013 Jun; 19(7):926-31. PubMed ID: 23012252 [TBL] [Abstract][Full Text] [Related]
6. Elevated fibrinogen levels in neuromyelitis optica is associated with severity of disease. Zhang Y; Zhang X; Liu D; Wang H; Pan S; Wang D; Chen X Neurol Sci; 2016 Nov; 37(11):1823-1829. PubMed ID: 27450097 [TBL] [Abstract][Full Text] [Related]
7. Low serum uric acid levels in patients with multiple sclerosis and neuromyelitis optica: An updated meta-analysis. Wang L; Hu W; Wang J; Qian W; Xiao H Mult Scler Relat Disord; 2016 Sep; 9():17-22. PubMed ID: 27645338 [TBL] [Abstract][Full Text] [Related]
8. Plasma sCD28, sCTLA-4 levels in neuromyelitis optica and multiple sclerosis during relapse. Wang H; Wang K; Zhong X; Dai Y; Wu A; Li Y; Hu X J Neuroimmunol; 2012 Feb; 243(1-2):52-5. PubMed ID: 22177277 [TBL] [Abstract][Full Text] [Related]
9. Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis. Chang KH; Tseng MY; Ro LS; Lyu RK; Tai YH; Chang HS; Wu YR; Huang CC; Hsu WC; Kuo HC; Chu CC; Chen CM Clin Chim Acta; 2013 Feb; 417():26-30. PubMed ID: 23262373 [TBL] [Abstract][Full Text] [Related]
10. Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica. Haghikia A; Kayacelebi AA; Beckmann B; Hanff E; Gold R; Haghikia A; Tsikas D Amino Acids; 2015 Sep; 47(9):1837-45. PubMed ID: 26055922 [TBL] [Abstract][Full Text] [Related]
11. Increased serum level of IL-37 in patients with multiple sclerosis and neuromyelitis optica. Farrokhi M; Rezaei A; Amani-Beni A; Etemadifar M; Kouchaki E; Zahedi A Acta Neurol Belg; 2015 Dec; 115(4):609-14. PubMed ID: 26008726 [TBL] [Abstract][Full Text] [Related]
12. Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis. Correale J; Fiol M Mult Scler; 2011 May; 17(5):521-31. PubMed ID: 21159721 [TBL] [Abstract][Full Text] [Related]
13. Increased serum matrix metalloproteinase-9 in neuromyelitis optica: implication of disruption of blood-brain barrier. Hosokawa T; Nakajima H; Doi Y; Sugino M; Kimura F; Hanafusa T; Takahashi T J Neuroimmunol; 2011 Jul; 236(1-2):81-6. PubMed ID: 21621856 [TBL] [Abstract][Full Text] [Related]
14. Correlation between serum thyroxine and complements in patients with multiple sclerosis and neuromyelitis optica. Zhang B; Jiang Y; Yang Y; Peng F; Hu X Neuro Endocrinol Lett; 2008 Apr; 29(2):256-60. PubMed ID: 18404143 [TBL] [Abstract][Full Text] [Related]
15. Serum antinuclear antibody may be associated with less severe disease activity in neuromyelitis optica. Masuda H; Mori M; Uzawa A; Muto M; Uchida T; Kuwabara S Eur J Neurol; 2016 Feb; 23(2):276-81. PubMed ID: 25903772 [TBL] [Abstract][Full Text] [Related]
16. Distinct serum cytokine profiles in neuromyelitis optica and multiple sclerosis. Wang KC; Lee CL; Chen SY; Chen JC; Yang CW; Chen SJ; Tsai CP J Interferon Cytokine Res; 2013 Feb; 33(2):58-64. PubMed ID: 23398365 [TBL] [Abstract][Full Text] [Related]
17. Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica. Shimizu Y; Ota K; Ikeguchi R; Kubo S; Kabasawa C; Uchiyama S J Neuroimmunol; 2013 Oct; 263(1-2):148-51. PubMed ID: 23910387 [TBL] [Abstract][Full Text] [Related]
18. Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica. Tortorella C; Ruggieri M; Di Monte E; Ceci E; Iaffaldano P; Direnzo V; Mastrapasqua M; Frigeri A; Amato MP; Hakiki B; Ghezzi A; Lugaresi A; De Luca G; Patti F; D'Amico E; Sola P; Simone AM; Svelto M; Livrea P; Trojano M J Neurol Neurosurg Psychiatry; 2011 Dec; 82(12):1355-9. PubMed ID: 21622936 [TBL] [Abstract][Full Text] [Related]
19. Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study. Duan Y; Liu Z; Liu Y; Huang J; Ren Z; Sun Z; Chen H; Dong H; Ye J; Li K Acta Radiol; 2017 Sep; 58(9):1132-1137. PubMed ID: 28173728 [TBL] [Abstract][Full Text] [Related]
20. Serum lipoprotein levels in patients with neuromyelitis optica elevated but had little correlation with clinical presentations. Li Y; Wang H; Hu X; Peng F; Yang Y Clin Neurol Neurosurg; 2010 Jul; 112(6):478-81. PubMed ID: 20399007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]